Abstract
Despite the use of Centers for Disease Control and Prevention (CDC) recommended practices to minimize infection risk, nosocomial sepsis and multiple organ failure (MOF) remain a leading cause of morbidity and mortality in critically ill patients. It is well documented that the use of immunosuppressant therapies dramatically increases this risk in patients with cancer, transplantation, and immunologic disease. Although immune monitoring has yet to be universally embraced, withdrawal of immunosuppressant therapies and use of immune restoration therapies is the standard of care when these patients develop sepsis. Critical illness stress can also induce a level of immunosuppression which is as life-threatening as is seen in the purposefully immunosuppressed patient. This chapter reviews the role of critical illness stress-induced immunosuppression in the development of nosocomial sepsis and MOF, and outlines clinical strategies which can be employed to maintain and restore immune function, and reduce morbidity and mortality in critically ill patients.
Chapter PDF
Similar content being viewed by others
Keywords
- Critical Illness
- Calcineurin Inhibitor
- Drotrecogin Alfa
- Endotoxin Tolerance
- Solid Organ Transplant Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Satoh S, Oishi K, Iwagaki A, et al (2001) Dexamethasone impairs pulmonary defence against Pseudomonas Aeruginosa through suppressing iNOS gene expression and peroxynitrite production by mice Clin Exp Immunol 126:266–273
Hurwitz CA, Silverman LB, Schorin MA, et al (2000) Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer 88:1964–1999
Hirano T, Horigome A, Takatani M, Oka K (2001) Cortisone counteracts apoptosis inducing effect of cortisol in human peripheral blood mononuclear cells. Int Immunopharmacol 1:2109–2115
Green DR, Beere HM (2000) Apoptosis. Gone but not forgotten. Nature 405:28–29
Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA (2005) Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nososcomial sepsis and multiple organ failure. J Immunol 174:3765–3772
Volk HD, Reinke P, Docke WD (1999) Immunological monitoring of the inflammatory process: Which variables? When to assess? Eur J Surg Suppl (584):70–72
Smith TJ, Khatcheressian J, Lyman GH, et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence based clinical pratcice guideline. J Clin Oncol 24:3187–3205
Sparrelid E, Emanuel F, Fehninger T, Andersson U, Andersson J (1997) Interstitial pneumonitis in bone marrow transplant recipients is associated with local production of TH2-type cytokines and lack of T cell mediated cytotoxicity. Transplantation 63:1782–1789
Volk HD, Reinke P, Krausch D, et al (1996) Monocyte deactivation — rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22(Suppl 4):S474–481
Hotchkiss RS Nicholson DW (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6:813–822
Chaudry IH, Samy TS, Schwacha MG, et al (2003) Endocrine targets in experimental shock. J Trauma 54(Suppl 5):S118–125
Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G (2004) Vasopressors for shock. Cochrane Database Syst Rev CD003709
Millbrandt EB, Kersten A, Kong L, et al (2005) Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 33:226–229
Brooks WA, Yunus M, Santosham M, et al (2004) Zinc for severe pneumonia in very young children: double blind placebo controlled trial. Lancet 363:1683–1688
Darlow BA, Austin NC (2003) Selenium supplementation to prevent short term morbidity in pre term neonates. Cochrane Database Syst Rev CD003312
Hotchkiss RS, Chang KC, Grayson MH, et al (2003) Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA 100:6724–6729
Avdi NJ, Nick JA, Whitlock BB, et al (2001) Tumor necrosis factor alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. J Biol Chem 276:2189–2199
Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW (2002) A randomized phase II trial of granulocyte macrophage colony stimulating factor therapy in severe sepsis with respiratory function. Am J Respir Crit Care Med 166:138–142
Plotz FB, Vreugdenhil HA, Slutsky AS, et al (2002) Mechanical ventilation alters the immune response in children without lung pathology. Intensive Care Med 28:486–492
Ranieri VM, Suter PM, Tortorella C, et al (1999) Effect of mechanical ventilation on inflammatory mediators in patients with acute respirtaory distress syndrome: a randomized controlled trial. JAMA 282:54–61
The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A (2004) Innate immune response in TH1 and TH2 dominant mouse strains. Shock 22:460–468
Wysocka M, Montaner LJ, Karp CL (2005) Flt 3 ligand treatment reverses endotoxin tolerance related immunoparalysis. J Immunol 174:7396–7402
Randow F, Docke WD, Bundschuh DS, et al (1997) In vitro prevention and reversal of lipopolysaccharide desensitization by IFN gamma, IL-12, and granulocyte macrophage colony stimulating factor. J Immunol 158:2911–2918
Bundshuh DS, Barsig J, Hartung T, et al (1997) Granulocyte macrophage colony stimulating factor and IFN gamma restore the systemic TNF alpha response to endotoxin in liposacchariade desensitized mice. J Immunol 158:2862–2871
Docke WD, Randow F, Syrbe U, et al (1997) Monocyte deactivation in septic patients: retsortaion by IFN-gamma treatment. Nat Med 3:678–681
Rosenbloom AJ, Linden PK, Dottance A, et al (2005) Effect of granulocyte-monocyte colony stimulating factor therapy on leukocyte function and clearance of serious infection in non-neutropenic patients. Chest 127:2139–2150
Barie PS, Williams MD, McCollam JS, et al (2004) Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188:212–220
Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD (2005) Chronic morphine treatment promotes specific TH2 cytokine production by nurine T cells in vitro via a Fas/Fas ligand-dependent mechanisms. J Immunol 175:4999–5005
van den Berghe G, Wouters P, Weekers F, et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Williams MD, Braun LA, Cooper LM, et al (2004) Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 8:R291–298
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science + Business Media Inc.
About this paper
Cite this paper
Carcillo, J.A. (2007). Critical Illness Stress-induced Immune Suppression. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-49518-7_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-49518-7_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-49517-0
Online ISBN: 978-0-387-49518-7
eBook Packages: MedicineMedicine (R0)